Hindmarsh P C, Smith P J, Pringle P J, Brook C G
Endocrine Unit, Middlesex Hospital, London, UK.
Clin Endocrinol (Oxf). 1988 May;28(5):559-63. doi: 10.1111/j.1365-2265.1988.tb03691.x.
In 35 children (22 M, 13 F) aged between 5.3 years and 10.3 years who received Somatrem therapy for 1 year there was a curvi-linear relationship between pretreatment GH sensory status (x) and response (y) (change in height velocity standard deviation score (SDS)) to therapy described by the equation y = A + B (e-Cx). A, B and C are constants. Dose of GH administered was found to be an important additional factor in determining response to therapy. This was confirmed by stepwise multiple regression which resulted in a correlation coefficient of 0.74. These data suggest that in the assessment of response to GH therapy, pretreatment height velocity and/or GH secretory status as well as dose and frequency of GH administration need to be taken into account.
在35名年龄在5.3岁至10.3岁之间接受生长激素释放因子治疗1年的儿童(22名男性,13名女性)中,治疗前生长激素感觉状态(x)与治疗反应(y)(身高速度标准差评分(SDS)的变化)之间存在曲线关系,由方程y = A + B(e-Cx)描述。A、B和C为常数。发现给予的生长激素剂量是决定治疗反应的一个重要附加因素。逐步多元回归证实了这一点,其相关系数为0.74。这些数据表明,在评估生长激素治疗反应时,需要考虑治疗前的身高速度和/或生长激素分泌状态以及生长激素给药的剂量和频率。